28567000|t|Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype.
28567000|a|Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disorder affecting motor neurons (MNs). Evidences indicate that ALS is a non-cell autonomous disease in which glial cells participate in both disease onset and progression. Exosomal transfer of mutant copper-zinc superoxide dismutase 1 (mSOD1) from cell-to-cell was suggested to contribute to disease dissemination. Data from our group and others showed that exosomes from activated cells contain inflammatory-related microRNAs (inflamma-miRNAs) that recapitulate the donor cell. While glia-derived exosomes and their effects in neurons have been addressed by several studies, only a few investigated the influence of motor neuron (MN)-derived exosomes in other cell function, the aim of the present study. We assessed a set of inflamma-miRs in NSC-34 MN-like cells transfected with mutant SOD1(G93A) and extended the study into their derived exosomes (mSOD1 exosomes). Then, the effects produced by mSOD1 exosomes in the activation and polarization of the recipient N9 microglial cells were investigated. Exosomes in coculture with N9 microglia and NSC-34 cells [either transfected with either wild-type (wt) human SOD1 or mutant SOD1(G93A)] showed to be transferred into N9 cells. Increased miR-124 expression was found in mSOD1 NSC-34 cells and in their derived exosomes. Incubation of mSOD1 exosomes with N9 cells determined a sustained 50% reduction in the cell phagocytic ability. It also caused a persistent NF-kB activation and an acute generation of NO, MMP-2, and MMP-9 activation, as well as upregulation of IL-1beta, TNF-alpha, MHC-II, and iNOS gene expression, suggestive of induced M1 polarization. Marked elevation of IL-10, Arginase 1, TREM2, RAGE, and TLR4 mRNA levels, together with increased miR-124, miR-146a, and miR-155, at 24 h incubation, suggest the switch to mixed M1 and M2 subpopulations in the exosome-treated N9 microglial cells. Exosomes from mSOD1 NSC-34 MNs also enhanced the number of senescent-like positive N9 cells. Data suggest that miR-124 is translocated from the mSOD1 MNs to exosomes, which determine early and late phenotypic alterations in the recipient N9-microglial cells. In conclusion, modulation of the inflammatory-associated miR-124, in mSOD1 NSC-34 MNs, with potential benefits in the cargo of their exosomes may reveal a promising therapeutic strategy in halting microglia activation and associated effects in MN degeneration.
28567000	14	20	NSC-34	CellLine	CVCL:D356
28567000	50	54	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
28567000	104	113	Microglia	Disease	
28567000	125	154	Amyotrophic lateral sclerosis	Disease	MESH:D000690
28567000	156	159	ALS	Disease	MESH:D000690
28567000	184	210	neurodegenerative disorder	Disease	MESH:D019636
28567000	266	269	ALS	Disease	MESH:D000690
28567000	439	444	mSOD1	Gene	110804
28567000	599	611	inflammatory	Disease	MESH:D007249
28567000	631	639	inflamma	Disease	
28567000	930	938	inflamma	Disease	
28567000	947	956	NSC-34 MN	CellLine	CVCL:U508
28567000	992	996	SOD1	Gene	20655
28567000	997	1001	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
28567000	1055	1060	mSOD1	Gene	110804
28567000	1102	1107	mSOD1	Gene	110804
28567000	1169	1171	N9	CellLine	CVCL:0452
28567000	1235	1237	N9	CellLine	CVCL:0452
28567000	1238	1247	microglia	Disease	
28567000	1252	1258	NSC-34	CellLine	CVCL:D356
28567000	1312	1317	human	Species	9606
28567000	1318	1322	SOD1	Gene	6647
28567000	1333	1337	SOD1	Gene	6647
28567000	1338	1342	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
28567000	1375	1377	N9	CellLine	CVCL:0452
28567000	1427	1432	mSOD1	Gene	110804
28567000	1433	1439	NSC-34	CellLine	CVCL:D356
28567000	1491	1496	mSOD1	Gene	110804
28567000	1511	1513	N9	CellLine	CVCL:0452
28567000	1665	1670	MMP-2	Gene	17390
28567000	1676	1681	MMP-9	Gene	17395
28567000	1721	1729	IL-1beta	Gene	16176
28567000	1731	1740	TNF-alpha	Gene	21926
28567000	1742	1748	MHC-II	Gene	111364
28567000	1754	1758	iNOS	Gene	18126
28567000	1835	1840	IL-10	Gene	16153
28567000	1842	1852	Arginase 1	Gene	11846
28567000	1854	1859	TREM2	Gene	83433
28567000	1861	1865	RAGE	Gene	11596
28567000	1871	1875	TLR4	Gene	21898
28567000	1922	1930	miR-146a	Gene	387164
28567000	1936	1943	miR-155	Gene	387173
28567000	2041	2043	N9	CellLine	CVCL:0452
28567000	2076	2081	mSOD1	Gene	110804
28567000	2082	2088	NSC-34	CellLine	CVCL:D356
28567000	2145	2147	N9	CellLine	CVCL:0452
28567000	2206	2211	mSOD1	Gene	110804
28567000	2300	2302	N9	CellLine	CVCL:0452
28567000	2354	2366	inflammatory	Disease	MESH:D007249
28567000	2390	2395	mSOD1	Gene	110804
28567000	2396	2402	NSC-34	CellLine	CVCL:D356
28567000	2518	2527	microglia	Disease	
28567000	2565	2580	MN degeneration	Disease	MESH:D009410
28567000	Positive_Correlation	110804	17390
28567000	Positive_Correlation	110804	17395
28567000	Positive_Correlation	110804	21926
28567000	Positive_Correlation	110804	18126
28567000	Positive_Correlation	110804	16176
28567000	Positive_Correlation	110804	111364

